Enbrel approved for pediatric psoriasis

| Melissa Leavitt

For the first time, the U.S. Food and Drug Administration (FDA) has approved a biologic medication for the treatment of pediatric plaque psoriasis.

On Nov. 4, 2016, the FDA approved Enbrel (etanercept) for the treatment of chronic moderate to severe plaque psoriasis in children ages 4 to 17.

One of the earliest biologics on the market, Enbrel has been approved for the treatment of psoriasis in adults since 2004. It is an injectable medication that works by lowering the activity of a protein known as tumor necrosis factor-alpha.

The protein, called a cytokine, is released by the immune system to trigger inflammation.

Even though Enbrel is new to pediatric psoriasis, it’s been used for more than a decade to treat children with juvenile idiopathic arthritis, according to Enbrel’s website.

It has also been investigated as potential medication for pediatric psoriasis for several years.

A study published in February 2016 in the Journal of the American Academy of Dermatology tested the long-term effects of Enbrel as a treatment for children with psoriasis. According to the results of the study, which involved almost 70 children ranging in age from 4 to 17, Enbrel stayed safe and effective for up to five years.

The most common adverse events experienced by children in the study included headache, upper respiratory tract infection and the common cold, as reported in the study.

Enbrel is manufactured by Amgen.

For more information on Enbrel, or other treatments for pediatric psoriasis, visit NPF’s Patient Navigation Center.

 

 


Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

Doctor and patient in the exam room
What does your primary care provider have to do with managing your psoriatic...
People meeting around a table for discussion
Have we developed the tools to turn psoriasis and psoriatic arthritis into...
The Patient Navigation Center helps a woman whose PsA went undiagnosed for...
hands holding signs numbers 1 through 5
Psoriatic arthritis is a complicated disease. Learn something new today.
FDA approval stamp
Clinical trial data show drug may help you achieve clear skin.
Test tubes in a lab
A study of immune cells points to clues on how psoriasis makes a person more...
Man with joint pain
A physical therapist weighs in on the exercises and activities you can do even...
NPF volunteer at a Team NPF Cycle event
When a new doctor finally took a close look at all of Erin Faulhaber’s symptoms...
Advocates visiting Congress
Forced to retire early because of his PsA, former diplomat Stephen Keat...